This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Synthon B.v.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Manuel Gago Guillan: Innovator in Pharmaceutical Compositions
Introduction
Manuel Gago Guillan is a notable inventor based in Sant Boi de Llobregat, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative tablet compositions. With a total of 2 patents to his name, his work has the potential to impact the medical community positively.
Latest Patents
One of his latest patents is a pharmaceutical composition comprising axitinib. This invention relates to an immediate release tablet composition characterized by a specific XRPD pattern. The composition exhibits a dissolution rate between 40% and 70% in 30 minutes when tested under specific conditions. Another significant patent involves tablet compositions comprising abiraterone acetate, aimed at providing immediate release of the drug in the stomach for effective oral administration.
Career Highlights
Manuel Gago Guillan is associated with Synthon B.V., a company known for its focus on developing complex pharmaceuticals. His work at Synthon has allowed him to explore innovative solutions in drug formulation, contributing to advancements in the pharmaceutical industry.
Collaborations
Throughout his career, Manuel has collaborated with talented individuals such as Rohit Kumar and Lisardo Alvarez Fernandez. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.
Conclusion
Manuel Gago Guillan stands out as an influential inventor in the pharmaceutical sector. His innovative patents and contributions to drug formulation highlight his commitment to improving healthcare solutions. His work continues to inspire advancements in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
